Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1968; 19(03/04): 547-555
DOI: 10.1055/s-0038-1651234
DOI: 10.1055/s-0038-1651234
Originalarbeiten – Original Articles – Travaux Originaux
Studies on the Hypercoagulable State
The Regulation of Fibrinogen Production in Experimental Hyper- and HypofibrinogenemiaFurther Information
Publication History
Publication Date:
27 June 2018 (online)

Summary
The intravenous injection of fibrinogen was associated with a prolonged hyperfibrinogenemia in the rabbit, out of proportion to the amount of fibrinogen administered. Factors V, II, VII and X activities were found to be elevated in the plasma simultaneously.
A similar pattern of changes was observed in the rabbit after the recovery period from thrombin-induced defibrination.
Based on the observations reported here, it was suggested that some fibrinogen or fibrin break-down products deliver the stimulatory message to the liver for increased fibrinogen production.
The possible relationship between these observations and hypercoagulable state has been discussed.
-
References
- 1 Izak G, Galewski K, Eyal Z. Studies on Hypercoagulable State The application of 131I-labelled fibrinogen for the estimation of intravascular coagulation in human subjects.. Throm-bos. Diathes. haemorrh. (Stuttg.) 1967; 18: 544
- 2 Izak G, Galewski K. Studies on Experimentally Induced Hypercoagulable State in Rabbits.. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 16: 228
- 3 Lowry O.H, Rosebrough N.J, Farr A.L, Randall R.J. Protein Measurement with the Folin Phenol Reagent.. J. biol. Chem 1951; 193: 265
- 4 Ratnoff O.D, Menzie C. A New Method for Determination of Fibrinogen in Small Samples of Plasma.. J. Lab. clin. Med 1951; 37: 316
- 5 Owren P.A, Aas K. Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and Proconvertin.. Scand. J. clin. Lab. Invest 1951; 3: 201
- 6 Bachman F, Duckert F, Koller F. The Stuart-Prower Factor and its Clinical Significance.. Thrombos. Diathes. haemorrh. (Stuttg.) 1958; 2: 24
- 7 Borchgrevink G.F, Pool J.G, Stormorken H. Assay for Factor V (Proaccelerin-Accelerin) Using Russel Viper Venom.. J. Lab. clin. Med 1960; 55: 625
- 8 von Kaulla K.N, Schultz R.L. Methods for the Estimation of Human Fibrinolysis.. Amer. J. clin. Path 1958; 29: 104
- 9 Ebough F.G, Emerson C.P, Ross J.F. The Use of Radioactive Ca51 as an Erythrocyte Tagging Agent for the Determination of Red Cell Survival in vivo.. J. clin. Invest 1953; 32: 1260
- 10 Ouchterlouny O. Antigen-Antibody Reaction in Gels.. Acta path. microbiol. scand 1949; 26: 507
- 11 Monkhouse F.C, Milojevic S. Changes in Fibrinogen level after Infusion of Thrombin and Thromboplastin.. Amer. J. Physiol 1960; 199: 1165
- 12 Adelson E. Fibrinogen and Fibrin Normal Metabolism.. Fed. Proc 1965; 24: 810
- 13 Lorand L. Physiological Role of Fibrinogen and Fibrin.. Fed. Proc 1965; 24: 784
- 14 Spaet T.H, Horowitz H.I, Zucker-Franklin D, Cintron Z, Biezenski J.J. Reticuloendothelial Clearance of Blood Thromboplastin by Rats.. Blood 1961; 17: 196
- 15 McFarlane A.S, Todd D, Cromwell S. Fibrinogen Catabolism in Humans.. Clin. Sci 1964; 26: 415
- 16 Lewis J.H, Szeto I.L. Clearance of Infused Fibrin.. Fed. Proc 1965; 24: 840
- 17 Winkert J, Ball R, Barone A, Winkert E, Kleiner S. Fibrinogen Accumulation and Synthesis in Serum Treated Rats.. Fed. Proc 1964; 23: 355
- 18 Deykin D. Thrombogenesis.. New Engl. J. Med 1967; 276: 622
- 19 Amundsen M.A, Spittell J.A, Thrompson J.K, Owen C.A. Hypercoagulability Associated with Malignant Disease and with Post-operative State.. Ann. int. Med 1963; 58: 608
- 20 Ratnojf O.D. Bleeding Syndromes.. p. 81 Charles C. Thomas Company; Springfield, Ill., USA: 1960
- 21 Rachmilewitz E.A, Schenker J, Kropatkin M.L. Defibrination Syndrome Followed by Hypercoagulable State.. Thrombos. Diathes. haemorr. (Stuttg.) 1967; 17: 120